Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Levosimendan 2.5 MG/ML Injectable Solution
DRUG
2 trials
Sponsors
University Hospital Dubrava
, Pr Bruno LEVY
Conditions
Biventricular Failure
Cardiogenic Shock
Left Ventricular Dysfunction
Right Ventricular Dysfunction
Phase 3
Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock
Recruiting
NCT04020263
Pr Bruno LEVY
Cardiogenic Shock
Start: 2023-07-03
End: 2028-01-03
Target: 610
Updated: 2025-08-05
Unknown Phase
Levosimendan In Patients Undergoing LVAD Implantation
NCT03659851
University Hospital Dubrava
Biventricular Failure, Left Ventricular Dysfunction, Right Ventricular Dysfunction
Start: 2009-06-01
End: 2021-12-31
Target: 50
Updated: 2020-04-03